DNA Analysis Finds New Target for Diabetes Drugs
NIH Director's Blog: Drug Development
MARCH 11, 2014
Credit: Jane Ades, National Human Genome Research Institute, NIH Type 2 diabetes (T2D) tends to run in families, and over the last five years the application of genomic technologies has led to discovery of more than 60 specific DNA variants that contribute to risk. Nat Rev Drug Discov. 2013 Aug;12(8):581-94. [3]
Let's personalize your content